p16INK4A in routine practice as a marker of cervical epithelial neoplasia

Gynecologic Oncology

Volumn 115, Issue 1, 2009, Pages 127-131

  Kurshumliu, Fisnik ^a   Thorns, Christoph ^b   Gashi Luci, Lumturije ^a  

^a UNIVERSITY OF PRISHTINA   (Serbia)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Cervical cancer; Epithelial neoplasia; Immunocytochemistry; Immunohistochemistry; p16INK4a

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER;

ARTICLE; CANCER SCREENING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; BIOPSY; BIOSYNTHESIS; METABOLISM; PATHOLOGY; UTERINE CERVIX TUMOR;

BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 69249220129     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.06.020     Document Type: Article

References (32)

1. International Agency for Research on Cancer. Cervix Cancer Screening (2005), IARC Press, Lyon
2. Boyle P. The globalisation of cancer. Lancet 368 (2006) 629-630
3. Biscotti C.V., Dawson A.E., and Dziura B. Assisted primary screening using the automated ThinPrep Imaging System. Am. J. Clin. Pathol. 123 (2005) 281-287
4. Dziura B., Quinn S., and Richard K. Performance of an imaging system vs. manual screening in the detection of squamous intraepithelial lesions of the uterine cervix. Acta Cytol. 50 (2006) 309-311
5. Grace A., McBrearty P., Troost S., Thonhill M., Kay E., and Leader M. Comparative study: conventional cervical and ThinPrep Pap tests in a routine clinical setting. Cytopathol. 13 (2002) 200-205
6. Broker T.R., Jin G., and Croom-Rivers A. Viral latency - the papillomavirus model. Dev. Biol. 106 (2001) 443-451
7. Barron B.A., and Richart R.M. A statistical model of the natural history of cervical carcinoma based on a prospective study of 557 cases. J. Natl. Cancer Inst. 41 (1968) 1343-1353
8. Cuzick J., Clavel C., Petry K.U., Meijer C.J.L.M., Hoyer H., Ratnam S., et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int. J. Cancer 119 (2006) 1095-1101
9. Riethdorf L., Riethdorf S., Lee K.R., Cviko A., Loning T., and Crum C.P. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. Hum. Pathol. 33 (2002) 899-904
10. Swan D.C., Tucker R.A., Tortolero-Luna G., Mitchell M.F., Wideroff L., Unger E.R., et al. Human papillomavirus DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol 37 (1999) 1030-1034
11. Fontaine J. High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV. AIDS 19 (2005) 785-794
12. INK4a as a complementary marker of high-grade intraepithelial lesions of the uterine cervix.I: experience with squamous lesions in 189 consecutive cervical biopsies. Anat. Pathol. 37 (2005) 112-124
13. INK4a expression in cervical intraepithelial neoplasia of adolescents. Mod. Pathol. 18 (2005) 267-273
14. INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am. J. Surg. Pathol. 25 (2001) 884-891
15. INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer 92 (2001) 276-284
16. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur. J. Cancer 38 (2002) 2229-2242
17. Missaoui N., Hmissa S., Frappart L., Trabelsi A., Abdelkader A.B., Traore C., et al. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma. Virchows Archiv. 448 (2006) 597-603
18. INK4a expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear - a comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecol. Oncol. 97 (2005) 35-40
19. Anderson M.B., and Jones B.A. False positive cervicovaginal cytology: a follow-up study. Acta Cytol. 41 (1997) 1697-1700
20. Fahey M.T., Irwig L., and Macaskill P. Meta-analysis of Pap test accuracy. Am. J. Epidemiol. 141 (1995) 680-689
21. Felix J., Lonky N., Tamura K., Yu K.J., Naidu Y., Lai C.R., et al. Aberrant expression of E-cadherin in cervical intraepithelial neoplasia correlates with a false negative Papanicolaou smear. Am. J. Obstet. Gynecol. 186 (2002) 1308-1314
22. INK4a expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod. Pathol. 16 (2003) 665-673
23. Dillner J. The serological response to papillomaviruses. Semin. Cancer Biol. 9 (1999) 423-430
24. INK4a protein in scraped cervical cells. Acta Cytol. 47 (2003) 616-623
25. INK4a assay. Correlation with biopsy follow-up results. Cancer Cytopathology 111 (2007) 83-92
26. INK4a and hybrid capture 2 human papilloma virus testing for high-grade cervical intraepithelial neoplasia. Am. J. Clin. Pathol. 122 (2004) 894-901
27. Parkkinen S., Mantyjarvi R., Syrjanen K., and Ranki M. Detection of human papillomavirus DNA by the nucleic acid sandwich hybridization method from cervical scraping. J. Med. Virol. 20 (1986) 279-288
28. ASC-US LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am. J. Obstet. Gynecol. 188 (2003) 1383-1392
29. INK4a-positive cells in cervical cytology samples. Acta Cytologica 48 (2004) 771-782
30. INK4a-stained cervical squamous cells in liquid-based cytology samples. Cancer Cytopathology 105 (2005) 461-467
31. INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am. J. Surg. Pathol. 27 (2003) 187-193
32. Hariri J., and Øster A. The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix. Int. J. Gynecol. Pathol. 26 (2007) 223-228